Clinical Trials Directory

Trials / Completed

CompletedNCT03962478

Combined Stent Insertion and HIFU Ablation for Pancreatic Carcinoma With Biliary Obstruction

Combined Stent Insertion and High-intensity Focused Ultrasound Ablation for Pancreatic Carcinoma With Biliary Obstruction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
92 (actual)
Sponsor
Xuzhou Central Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the clinical effectiveness and long-term outcomes between patients with pancreatic carcinoma and biliary obstruction who are treated by stent insertion with or without high-intensity focused ultrasound ablation.

Detailed description

Distal malignant biliary obstruction is a common problem in patients with pancreatic carcinoma. In unresectable pancreatic carcinomas, percutaneous stent placement has been pivotal in providing relief from obstructive jaundice, improving the quality of life, and allowing the maintenance of anticancer treatment. Venous chemotherapy, transcatheter arterial chemoembolization, or radiotherapy have been used to prolong stent patency and survival after stent insertion for patients with pancreatic carcinoma and biliary obstruction. High-intensity focused ultrasound ablation is a noninvasive and atoxic treatment of malignant tumor using focused ultrasound energy from an extracorporeal source that is targeted within the body resulting in thermally induced necrosis and apoptosis. The purpose of this study is to compare the clinical effectiveness and long-term outcomes between patients with pancreatic carcinoma and biliary obstruction who are treated by stent insertion with or without high-intensity focused ultrasound ablation.

Conditions

Interventions

TypeNameDescription
DEVICEbiliary stent and high-intensity focused ultrasound ablation systemSelf-expandable biliary nitinol alloys stent and YDME FEP-BY02 high-intensity focused ultrasound equipment
DEVICEbiliary stentSelf-expandable biliary nitinol alloys stent

Timeline

Start date
2019-05-31
Primary completion
2020-02-08
Completion
2020-09-28
First posted
2019-05-24
Last updated
2020-09-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03962478. Inclusion in this directory is not an endorsement.